Elzbieta Golebiowska (born 1954) biomedical laboratory scientist in the Section of Immunohaematology.
The author has completed the ICMJE form and declares the following conflict of interest: The department received funding from Alexion (manufacturer of eculizumab) for three projects related to PNH in 2009, including the current work.
Department of Immunology and Transfusion Medicine
Oslo University Hospital